FollowMyHealth Patient Portal

Farrokh Dehdashti, MD

Professor, Radiology
Division of Nuclear Medicine

Specialty Areas

Nuclear Medicine
Radiology
PET Imaging

Board Certifications

Nuclear Medicine

Hospital Affiliations

Barnes-Jewish Hospital
St. Louis Children's Hospital
Barnes-Jewish West County Hospital

Areas of Clinical Interest

Oncologic applications of positron emission tomography such as receptor imaging in breast and prostate cancers, hypoxia imaging in various cancers, and imaging tumor proliferation.

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Barnes-Jewish Hospital
Mallinckrodt Institute of Radiology

510 South Kingshighway Boulevard
St. Louis, MO 63110

Office Phone: 314-362-1952
Fax: 314-362-5428

Center for Advanced Medicine - South County

5201 Midamerica Plaza
St. Louis, MO 63129

Education

Education

Fellowship: PET Imaging, Division of Nuclear Medicine, Washington University School of Medicine, St. Louis, MO 1990
Chief Residency: Nuclear Medicine, Washington University School of Medicine, St. Louis, MO 1989
Resident/Chief Res.: Nuclear Medicine, Medical College of Wisconsin, Milwaukee, WI 1988
Chief Residency: Radiology, Pahlavi University, Shiraz, Iran 1980
Residency: Radiology, Pahlavi University Hospitals, Shiraz, Iran 1979
Medical Degree: Pahlavi University School of Medicine, Shiraz, Iran 1977
PreMedicine Training: College of Arts and Science, Pahlavi University Hospitals, Shiraz, Iran 1970

Publication & Research

Publication & Research

Evaluation of [<sup>89</sup>Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA
Breast Cancer Res Treat. 2018 Feb 13; doi: 10.1007/s10549-018-4696-z.

PMID:
    29442264
    [PubMed - as supplied by publisher]
Related citations


Extensive Metastatic Sarcomatoid Renal Cell Carcinoma Evaluated by <sup>18</sup>F-FDG PET/CT: a Case Report and Review of Literature.
Fuser D, Hedberg ML, Dehner LP, Dehdashti F, Siegel BA
J Kidney Cancer VHL. 2018; 5(1)1-6. doi: 10.15586/jkcvhl.2018.99.

PMID:
    29354391
    [PubMed]
Related citations


Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent.
Marquez-Nostra BV, Lee S, Laforest R, Vitale L, Nie X, Hyrc K, Keler T, Hawthorne T, Hoog J, Li S, Dehdashti F, Ma CX, Lapi SE
Oncotarget. 2017 Nov 28; 8(61)104303-104314. doi: 10.18632/oncotarget.22228.

PMID:
    29262642
    [PubMed]
Related citations


Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
Markovina S, Wang S, Henke LE, Luke CJ, Pak SC, DeWees T, Pfeifer JD, Schwarz JK, Liu W, Chen S, Mutch D, Wang X, Powell MA, Siegel BA, Dehdashti F, Silverman GA, Grigsby PW
Br J Cancer. 2018 Jan; 118(1)72-78. doi: 10.1038/bjc.2017.390.

PMID:
    29112685
    [PubMed - in process]
Related citations


First-in-Man Evaluation of <sup>124</sup>I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment.
Laforest R, Dehdashti F, Liu Y, Frye J, Frye S, Luehmann H, Sultan D, Shan JS, Freimark BD, Siegel BA
Mol Imaging. 2017 Jan-Dec; 161536012117733349. doi: 10.1177/1536012117733349.

PMID:
    29037107
    [PubMed - in process]
Related citations


Preclinical Development of CD38-Targeted [<sup>89</sup>Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma.
Ghai A, Maji D, Cho N, Chanswangphuwana C, Rettig M, Shen D, DiPersio J, Akers W, Dehdashti F, Achilefu S, Vij R, Shokeen M
J Nucl Med. 2018 Feb; 59(2)216-222. doi: 10.2967/jnumed.117.196063.

PMID:
    29025987
    [PubMed - in process]
Related citations


Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial.
Uppaluri R, Winkler AE, Lin T, Law JH, Haughey BH, Nussenbaum B, Paniello RC, Rich JT, Diaz JA, Michel LP, Wildes T, Dunn GP, Zolkind P, Kallogjeri D, Piccirillo JF, Dehdashti F, Siegel BA, Chernock RD, Lewis JS Jr, Adkins DR
Clin Cancer Res. 2017 May 1; 23(9)2186-2194. doi: 10.1158/1078-0432.CCR-16-1469.

PMID:
    28151720
    [PubMed - indexed for MEDLINE]
Related citations


Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva.
Rao YJ, Hassanzadeh C, Chundury A, Hui C, Siegel BA, Dehdashti F, DeWees T, Mullen D, Powell MA, Mutch DG, Schwarz JK, Grigsby PW
Radiother Oncol. 2017 Mar; 122(3)445-451. doi: 10.1016/j.radonc.2016.12.019.

PMID:
    28063696
    [PubMed - indexed for MEDLINE]
Related citations


Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
Atri M, Zhang Z, Dehdashti F, Lee SI, Marques H, Ali S, Koh WJ, Mannel RS, DiSilvestro P, King SA, Pearl M, Zhou X, Plante M, Moxley KM, Gold M
Radiology. 2017 May; 283(2)450-459. doi: 10.1148/radiol.2016160200.

PMID:
    28051912
    [PubMed - indexed for MEDLINE]
Related citations


Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma.
Chatzkel J, Lewis JS Jr, Ley JC, Wildes TM, Thorstad W, Gay H, Daly M, Jackson R, Rich J, Paniello R, Nussenbaum B, Liu J, Siegel BA, Dehdashti F, Adkins D
Head Neck Pathol. 2017 Sep; 11(3)338-345. doi: 10.1007/s12105-016-0775-9.

PMID:
    28025779
    [PubMed - in process]
Related citations


Indeterminate Findings on Oncologic PET/CT: What Difference Does PET/MRI Make?
Fraum TJ, Fowler KJ, McConathy J, Dehdashti F
Nucl Med Mol Imaging. 2016 Dec; 50(4)292-299.

PMID:
    27994684
    [PubMed]
Related citations


[<sup>89</sup>Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.
Laforest R, Lapi SE, Oyama R, Bose R, Tabchy A, Marquez-Nostra BV, Burkemper J, Wright BD, Frye J, Frye S, Siegel BA, Dehdashti F
Mol Imaging Biol. 2016 Dec; 18(6)952-959.

PMID:
    27146421
    [PubMed - indexed for MEDLINE]
Related citations


The Emerging Role of PET/MR Imaging in Gynecologic Cancers.
Ponisio MR, Fowler KJ, Dehdashti F
PET Clin. 2016 Oct; 11(4)425-40. doi: 10.1016/j.cpet.2016.05.005.

PMID:
    27593247
    [PubMed - indexed for MEDLINE]
Related citations


Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.
Atri M, Zhang Z, Dehdashti F, Lee SI, Ali S, Marques H, Koh WJ, Moore K, Landrum L, Kim JW, DiSilvestro P, Eisenhauer E, Schnell F, Gold M
Gynecol Oncol. 2016 Sep; 142(3)413-9. doi: 10.1016/j.ygyno.2016.05.002.

PMID:
    27178725
    [PubMed - indexed for MEDLINE]
Related citations


Radioimmunotherapy-based conditioning for hematopoietic stem cell transplantation: Another step forward.
Ali AM, Dehdashti F, DiPersio JF, Cashen AF
Blood Rev. 2016 Sep; 30(5)389-99. doi: 10.1016/j.blre.2016.04.007.

PMID:
    27174151
    [PubMed - in process]
Related citations


Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.
Zhao Y, Detering L, Sultan D, Cooper ML, You M, Cho S, Meier SL, Luehmann H, Sun G, Rettig M, Dehdashti F, Wooley KL, DiPersio JF, Liu Y
ACS Nano. 2016 Jun 28; 10(6)5959-70. doi: 10.1021/acsnano.6b01326.

PMID:
    27159079
    [PubMed - in process]
Related citations


Clinical application of PET/MRI in oncology.
Sotoudeh H, Sharma A, Fowler KJ, McConathy J, Dehdashti F
J Magn Reson Imaging. 2016 Aug; 44(2)265-76. doi: 10.1002/jmri.25161.

PMID:
    27007987
    [PubMed - indexed for MEDLINE]
Related citations


Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.
Fowler AM, Clark AS, Katzenellenbogen JA, Linden HM, Dehdashti F
J Nucl Med. 2016 Feb; 57 Suppl 175S-80S. doi: 10.2967/jnumed.115.157933.

PMID:
    26834106
    [PubMed - indexed for MEDLINE]
Related citations


Phase 1 Evaluation of [(64)Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors.
Lockhart AC, Liu Y, Dehdashti F, Laforest R, Picus J, Frye J, Trull L, Belanger S, Desai M, Mahmood S, Mendell J, Welch MJ, Siegel BA
Mol Imaging Biol. 2016 Jun; 18(3)446-53. doi: 10.1007/s11307-015-0912-y.

PMID:
    26567113
    [PubMed - indexed for MEDLINE]
Related citations


PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer.
Bagade S, Fowler KJ, Schwarz JK, Grigsby PW, Dehdashti F
Semin Nucl Med. 2015 Jul; 45(4)293-303. doi: 10.1053/j.semnuclmed.2015.03.005.

PMID:
    26050657
    [PubMed - indexed for MEDLINE]
Related citations